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background: It has been reported that beta-blocker (BB) reduced cardiovascular events in patients with ischemic heart disease. However, little is 
known about the efficacy of BB in patients with critical limb ischemia (CLI).
methods: Between March 2004 and December 2011, 1873 CLI patients who underwent endovascular therapy (EVT) (394 BB-treated and 
1479 non-BB-treated) for de novo infrainguinal lesions were identified retrospectively. Propensity score analysis was used for risk adjustment 
in multivariable analysis and for one-to-one matching (305 patients in each). The primary endpoint was amputation-free survival (AFS), and the 
secondary endpoints were overall survival, limb salvage rate, freedom from major adverse limb events (MALE; repeat reintervention, surgical 
conversion and major amputation). The mean follow-up period was 22+/-15 months.
results: In the propensity score-matched pairs, there was no significant difference in AFS between patients treated with and without BB (58.8% vs. 
58.5% at 3-year, logtank p=0.76). Also, there is no significant difference in limb salvage (88.3% vs. 88.8 at 3-year, logtank P=0.41), overall survival 
(63.0% vs. 62.4% at 3 years, logrank P=0.70) and freedom from MALE (43.6% vs. 44.9% at 3 years, logrank P=0.58) in patietns treated with and 
without BB.
conclusions: Although the use of BB was not associated with the prognosis of limb, the mortality was also unaffect by BB use in CLI patients after 
EVT.
